Latest news
Gene therapy trial tests injection lasting three years
Posted: Friday 23 September 2022
A new clinical trial is underway to test a gene therapy which could treat wet age-related macular degeneration (AMD), with an eye injection lasting up to three years.
Find out more
Faricimab - all you need to know about the new treatment for wet AMD and DMO
Posted: Tuesday 30 August 2022
"There's a long way to go but I'm more optimistic. I was thinking of retiring a few years ago, now I'm so excited about the treatments we can offer patients I'll probably stay another few years."
Find out more
Thousands of patients with diabetes-related sight loss given access to new treatment
Posted: Thursday 11 August 2022
Thousands of patients with diabetic macular oedema (DMO) could benefit from a steroid treatment, which has previously only been available to those who have received cataract surgery.
Find out more
"It could be life-changing for so many people"
Posted: Wednesday 3 August 2022
A 75-year-old man involved in a clinical trial for a new implant for wet age-related macular degeneration (AMD) says it would be ‘magic’ if the trial is successful.
Find out more
Ophthalmologist to reveal more about new drug for two types of macular disease
Posted: Wednesday 3 August 2022
An ophthalmologist who has worked on the clinical trials for the latest drug approved to treat wet age-related macular degeneration (AMD) and diabetic macular oedema (DMO) will reveal more about the treatment and how you can access it, as part of the Macular Society’s monthly webinar series.
Find out more
New treatment option approved for patients with diabetic macular oedema
Posted: Thursday 28 July 2022
Patients living with diabetes-related sight loss could be treated with a new drug, following a recommendation from The National Institute for Health and Care Excellence (NICE).
Find out more
Cheaper drugs for wet AMD becoming available on the NHS
Posted: Tuesday 19 July 2022
New forms of anti-VEGF drugs will soon be available to treat wet age-related macular degeneration (AMD) thanks to the production of biosimilars.
Find out more
Gene editing to treat inherited macular disease
Posted: Tuesday 5 July 2022
A research team is making strides in using gene-editing techniques to treat a rare, inherited form of macular disease.
Find out more
Could zebrafish speed up macular research?
Posted: Thursday 30 June 2022
Scientists at the University of Sussex are looking into whether cells from the zebrafish eye can be manipulated to create a macula, which could be used in future research.
Find out more
Creating a wet AMD drug using flower compounds
Posted: Monday 20 June 2022
Scientists working to unleash the power of the well-renowned hyacinth plant have revealed more about their work to beat macular disease.
Find out more
Do plants hold the power to cure macular disease?
Posted: Monday 20 June 2022
Professor Dulcie Mulholland is studying the family of the hyacinth to find a new treatment for macular disease. Find out why she thinks plants could hold the answers we're looking for.
Find out more
New drug for Stargardt could reach patients faster
Posted: Friday 17 June 2022
A new drug to treat Stargardt disease has been granted a fast-track review by the Food and Drug Administration in the US, to help make it available to patients quicker.
Find out more
Get the latest news and advice from the Macular Society
To hear about life-changing research, treatments and tips for living with sight loss, subscribe to our monthly enewsletter today. Together we can Beat Macular Disease.
Sign up to our free email newsletter